If you liked this article you might like

Allergan, Editas Sign Gene-Editing Pact for Rare Eye Diseases
Biotech Premarket Movers: Editas, Amphastar, Aratana, Pacira
Editas Medicine COO to Leave Company
What Biotech Investors Can Expect From the J.P. Morgan Health Care Conference 2017